Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
Public ClinicalTrials.gov record NCT01042977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-week, Multicentre, Randomised, Double-blind,Age-stratified, Placebo Controlled Phase III Study With an 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Patients With T2DM and Cardiovascular Disease, Who Exhibit Inadequate Glycaemic Control on Usual Care
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is carried out to assess whether dapagliflozin improves glycemic control, decreases fasting plasma glucose levels, body weight and blood pressure when added to patient's existing medications and how it compares with their usual treatment without added dapagliflozin. Safety data will be collected and analysed to confirm that treatment with dapagliflozin is safe and well tolerated in patients who have diabetes and cardiovascular disease
Study identification
- NCT ID
- NCT01042977
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 964 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Feb 17, 2014
2010 – 2012
United States locations
- U.S. sites
- 57
- U.S. states
- 21
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Bell Gardens | California | — | — |
| Research Site | Chino | California | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Huntington Beach | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Mission Hills | California | — | — |
| Research Site | Redondo Beach | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Torrance | California | — | — |
| Research Site | Aventura | Florida | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Bradenton | Florida | — | — |
| Research Site | Brooksville | Florida | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Dania Beach | Florida | — | — |
| Research Site | Delray Beach | Florida | — | — |
| Research Site | New Smyrna Beach | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Avon | Indiana | — | — |
| Research Site | Franklin | Indiana | — | — |
| Research Site | Greenfield | Indiana | — | — |
| Research Site | Muncie | Indiana | — | — |
| Research Site | Waterloo | Iowa | — | — |
| Research Site | Topeka | Kansas | — | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | Alexandria | Louisiana | — | — |
| Research Site | Rockville | Maryland | — | — |
| Research Site | Kalamazoo | Michigan | — | — |
| Research Site | Livonia | Michigan | — | — |
| Research Site | Billings | Montana | — | — |
| Research Site | Berlin | New Jersey | — | — |
| Research Site | Brick | New Jersey | — | — |
| Research Site | Asheboro | North Carolina | — | — |
| Research Site | Fargo | North Dakota | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Altoona | Pennsylvania | — | — |
| Research Site | Erie | Pennsylvania | — | — |
| Research Site | Holland | Pennsylvania | — | — |
| Research Site | Lancaster | Pennsylvania | — | — |
| Research Site | Media | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Irving | Texas | — | — |
| Research Site | Richardson | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Sugarland | Texas | — | — |
| Research Site | Alexandria | Virginia | — | — |
| Research Site | Manassas | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01042977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2014 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01042977 live on ClinicalTrials.gov.